AR ‐V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration‐resistant prostate cancer patients

ConclusionThe CTC clusters and AR‐V7‐positive CTC clusters detected were important for assessing the response to abiraterone or enzalutamide therapy and for predicting disease outcome.

Source: The Prostate - March 5, 2018 Category: Urology & Nephrology Authors: Takatsugu Okegawa, Naoki Ninomiya, Kazuki Masuda, Yu Nakamura, Mitsuhiro Tambo, Kikuo Nutahara Tags: ORIGINAL ARTICLE Source Type: research